A molecular basis for resistance to liver damage from transfusional iron overload in sickle cell disease.

被引:0
|
作者
Hagar, W
Harmatz, P
Vichinsky, EP
Theil, EC
机构
[1] Childrens Hosp, Oakland Res Inst, Ctr BioIron, Oakland, CA 94609 USA
[2] Childrens Hosp & Res Ctr, Oakland, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2627
引用
收藏
页码:668A / 668A
页数:1
相关论文
共 50 条
  • [1] Deferasirox for managing transfusional iron overload in people with sickle cell disease
    Meerpohl, Joerg J.
    Antes, Gerd
    Ruecker, Gerta
    Fleeman, Nigel
    Niemeyer, Charlotte
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (08):
  • [2] Deferasirox for managing transfusional iron overload in people with sickle cell disease
    Meerpohl, Joerg J.
    Schell, Lisa K.
    Ruecker, Gerta
    Motschall, Edith
    Fleeman, Nigel
    Niemeyer, Charlotte M.
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05): : 1 - 77
  • [3] Transfusional Iron Overload and Iron Chelation Therapy in Thalassemia Major and Sickle Cell Disease
    Marsella, Maria
    Borgna-Pignatti, Caterina
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (04) : 703 - +
  • [4] Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease
    Brittenham, GM
    Sheth, S
    Allen, CJ
    Farrell, DE
    SEMINARS IN HEMATOLOGY, 2001, 38 (01) : 37 - 56
  • [5] Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload
    Thawer, Fahim
    Kutlar, Abdullah
    Bowman, Latanya
    Wells, Leigh
    Xu Hongyan
    Patel, Niren
    Bora, Pritam
    BLOOD, 2017, 130
  • [6] Hypoechoic lesions of the spleen in a patient with sickle cell disease as a sign of transfusional iron overload
    Distelmaier, L.
    Nensa, F.
    Roeth, A.
    Duehrsen, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 77 - 78
  • [7] Transfusional Iron Overload in Sickle Cell Patients:Outcomes of Chelation Therapy
    Adamkiewicz, Daniel
    Mangaonkar, Abhishek A.
    Son, James
    Xu, Hongyan
    Wells, Leigh
    Bowman, Latanya
    Kutlar, Abdullah
    BLOOD, 2021, 138
  • [8] A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
    Vichinsky, Elliott
    Onyekwere, Onyinye
    Porter, John
    Swerdlow, Paul
    Eckman, James
    Lane, Peter
    Files, Beatrice
    Hassell, Kathryn
    Kelly, Patrick
    Wilson, Felicia
    Bernaudin, Francoise
    Forni, Gian Luca
    Okpala, Iheanyi
    Ressayre-Djaffer, Catherine
    Alberti, Daniele
    Holland, Jaymes
    Marks, Peter
    Fung, Ellen
    Fischer, Roland
    Mueller, Brigitta U.
    Coates, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (03) : 501 - 508
  • [9] Is serum ferritin an accurate measure of transfusional iron overload in children with thalassaemia and sickle cell disease?
    Sharif, J.
    Horgan, C.
    Wijesinghe, D.
    Meyer, S.
    Will, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 189 - 189
  • [10] Correlation of Serum Ferritin Levels with Liver Iron Concentration By MRI Measurement in Sickle Cell Patients with Transfusional Iron Overload
    Ajebo, Germame
    Mangaonkar, Abhishek A.
    Ahmad, Imran
    Barrett, Nadine
    Wells, Leigh
    Patel, Niren
    Xu, Hongyan
    Kutlar, Abdullah
    BLOOD, 2018, 132